Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations
References (47)
- et al.
Calretinin, thrombomodulin, CEA and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma
Hum Pathol
(2001) The immunohistochemical diagnosis of epithelial mesothelioma
Hum Pathol
(1999)- et al.
p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens
Hum Pathol
(1994) - et al.
Immunohistochemical MIB-1 and p27kip1 as prognostic factors in pleural mesotheliomas
Pathol Res Pract
(2001) - et al.
Telomere end-replication problem and cell aging
J Mol Biol
(1992) - et al.
Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas
Chest
(1996) - et al.
Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas
Hum Pathol
(2001) - et al.
Significance of immunohistochemical detection of human telomerase reverse transcriptase
Am J Pathol
(2003) Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma
Am J Clin Pathol
(1999)- et al.
Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies
Am J Clin Pathol
(2001)
The role of immunohistochemistry in the diagnosis of malignant mesothelioma
Semin Diagn Pathol
Pleural biopsy in the diagnosis of malignant mesothelioma
Thorax
Reactive mesothelial hyperplasia vs. mesothelioma including mesothelioma in situ. A brief review
Am J Clin Pathol
US-Canadian Mesothelioma Reference Panel, The separation of benign and malignant mesothelial proliferations
Am J Surg Pathol
p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections
J Pathol
The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses
Cancer
Utility of epithelial membrane antigen and p53 in the differential diagnosis of benign reactive processes from malignancy in pleural biopsy specimens
Virchows Arch
Expression of desmin and smooth muscle actin in mesothelial hyperplasia and mesothelioma
J Pathol
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2
Histopathology
Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma
Histopathology
Immunobiochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki-67
Am J Pathol
MIB-1 proliferation index correlates with survival in pleural malignant mesothelioma
Histopathology
p27kip1 immunoreactivity correlates with long-term survival in pleural malignant mesothelioma
Cancer
Cited by (17)
Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions
2011, Journal of the Egyptian National Cancer InstituteCitation Excerpt :Taheri et al. [31] in another work evaluated the diagnostic value of ki67 and repp86 in differentiation of benign mesothelial proliferation from malignancy and reported 88% sensitivity and 92% specificity for ki67. Cakir et al. [9] evaluated telomerase activity and ki67 immunostaining to differentiate malignant from mesothelial proliferation and reported 74% sensitivity and 86% specificity for ki67. Kimura et al. [37] studied three proliferative markers (MCM7, Topo IIα, and ki67) to differentiate malignant from mesothelial proliferation and reported 64.3% sensitivity and 92.9% specificity for ki67 using 30% labeling index as cutoff point.
Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method
2007, Human PathologyCitation Excerpt :This finding is contrary to that of previous studies, perhaps because of the fact that all the noncancerous mucosal specimens we used for comparison were obtained from cancer-bearing stomachs. Both Ki-67 and h-TERT activities are reported to indicate proliferative activity in benign or malignant tumors [18] and to show mutual correlation in thyroid and esophageal tumors [19,20]. Overexpression of Ki-67 in tumors is considered to be a marker of proliferation and the metastatic potential of gastric cancer [21].
Epithelioid lesions of the serosa
2012, Archives of Pathology and Laboratory Medicine